Sharad K. Verma

EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations

Michael T. McCabe, Heidi M. Ott, Gopinath Ganji et al. · Nature · 2012 · 1.8K citations

Ezh2 Inhibition, Lymphoid Neoplasia, Hematological Malignancy +10

EZH2 Is Required for Germinal Center Formation and Somatic EZH2 Mutations Promote Lymphoid Transformation

Wendy Béguelin, Relja Popovic, Matt Teater et al. · Cancer Cell · 2013 · 828 citations · Full text

Chromatin, Developmental Biology, Germ Cell +9

Epigenomic alterations define lethal CIMP-positive ependymomas of infancy

Stephen C. Mack, Hendrik Witt, Rosario M. Piro et al. · Nature · 2014 · 610 citations · Full text

Developmental Anomaly, Epigenomic Alterations, Developmental Biology +8

Identification of Potent, Selective, Cell-Active Inhibitors of the Histone Lysine Methyltransferase EZH2

Sharad K. Verma, Xinrong Tian, Louis V. LaFrance et al. · ACS Medicinal Chemistry Letters · 2012 · 373 citations · Full text

Histone Modifications, Drug Discovery Program, Engineering +18

Cutaneous neurofibromas

Nicolás Ortonne, P. Wolkenstein, Jaishri O. Blakeley et al. · Neurology · 2018 · 106 citations · Full text